Myelodysplastic syndrome physical examination: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Mahshid |
||
| Line 22: | Line 22: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Revision as of 02:50, 27 November 2017
|
Myelodysplastic syndrome Microchapters |
|
Differentiating Myelodysplastic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myelodysplastic syndrome physical examination On the Web |
|
American Roentgen Ray Society Images of Myelodysplastic syndrome physical examination |
|
Risk calculators and risk factors for Myelodysplastic syndrome physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Common physical examination findings of myelodysplastic syndrome include pallor, hepatomegaly, splenomegaly, lymphadenopathy, fever, petechiae, and purpura.[1][2]
Physical Examination
Common physical examination findings of myelodysplastic syndrome include:[1][2]
- Pallor
- Hepatomegaly
- Splenomegaly
- Lymphadenopathy
- Diffuse erythematous rash
- Fever
- Petechiae
- Purpura
References
- ↑ 1.0 1.1 Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015
- ↑ 2.0 2.1 Mutlu, Hasan; Akca, Zeki; Uskudar Teke, Havva; Ugur, Hediye (2011). "Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline". The Eurasian Journal of Medicine. 42 (3): 173–176. doi:10.5152/eajm.2011.36. ISSN 1308-8734.